APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifaximin Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rifaximin Capsules Industry Growth and Trends Forecast to 2032

27 December 202599 pages

Choose your research edition.

Industry ResearchRifaximin Capsules Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifaximin Capsules Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Rifaximin Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifaximin Capsules Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifaximin Capsules Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Rifaximin Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rifaximin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rifaximin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifaximin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rifaximin Capsules include Aden Healthcare, Alfasigma SpA, Estrellas Life Sciences Private Limited, Hainan Hailing Chemical Pharmaceutical Co., Ltd., Hainan Sanye Pharmaceutical Factory Co., Ltd., Shanghai Xinya Pharmaceutical Minhang Co., Ltd. and Southwest Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rifaximin Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rifaximin Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rifaximin Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rifaximin Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rifaximin Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rifaximin Capsules Market by Company

Aden Healthcare

Alfasigma SpA

Estrellas Life Sciences Private Limited

Hainan Hailing Chemical Pharmaceutical Co., Ltd.

Hainan Sanye Pharmaceutical Factory Co., Ltd.

Shanghai Xinya Pharmaceutical Minhang Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Rifaximin Capsules Segment by Type

0.1g

0.2g

Rifaximin Capsules Segment by Application

Hospital

Clinic

Other

Rifaximin Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifaximin Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rifaximin Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rifaximin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.1g Table 2. Major Company of 0.2g Table 3. Global Rifaximin Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rifaximin Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Rifaximin Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rifaximin Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rifaximin Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Rifaximin Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Rifaximin Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Rifaximin Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rifaximin Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rifaximin Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Rifaximin Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Rifaximin Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Rifaximin Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rifaximin Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Rifaximin Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rifaximin Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Rifaximin Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rifaximin Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Rifaximin Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rifaximin Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Rifaximin Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Rifaximin Capsules Industry Trends Table 25. Rifaximin Capsules Industry Drivers Table 26. Rifaximin Capsules Industry Opportunities and Challenges Table 27. Rifaximin Capsules Industry Restraints Table 28. Global Rifaximin Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rifaximin Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Rifaximin Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Rifaximin Capsules Sales Share by Company (2021-2026) Table 32. Global Rifaximin Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Rifaximin Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rifaximin Capsules Major Company Production Sites and Headquarters Table 35. Global Rifaximin Capsules Company, Product Type & Application Table 36. Global Rifaximin Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rifaximin Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rifaximin Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rifaximin Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Rifaximin Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rifaximin Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rifaximin Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Rifaximin Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Rifaximin Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Rifaximin Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rifaximin Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rifaximin Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Rifaximin Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Rifaximin Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rifaximin Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Rifaximin Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rifaximin Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rifaximin Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Rifaximin Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Rifaximin Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Rifaximin Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rifaximin Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rifaximin Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Rifaximin Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Rifaximin Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Rifaximin Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rifaximin Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Rifaximin Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rifaximin Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Rifaximin Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rifaximin Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Rifaximin Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rifaximin Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Rifaximin Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Aden Healthcare Company Information Table 72. Aden Healthcare Business Overview Table 73. Aden Healthcare Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aden Healthcare Rifaximin Capsules Product Portfolio Table 75. Aden Healthcare Recent Development Table 76. Alfasigma SpA Company Information Table 77. Alfasigma SpA Business Overview Table 78. Alfasigma SpA Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Alfasigma SpA Rifaximin Capsules Product Portfolio Table 80. Alfasigma SpA Recent Development Table 81. Estrellas Life Sciences Private Limited Company Information Table 82. Estrellas Life Sciences Private Limited Business Overview Table 83. Estrellas Life Sciences Private Limited Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Estrellas Life Sciences Private Limited Rifaximin Capsules Product Portfolio Table 85. Estrellas Life Sciences Private Limited Recent Development Table 86. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information Table 87. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview Table 88. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio Table 90. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Development Table 91. Hainan Sanye Pharmaceutical Factory Co., Ltd. Company Information Table 92. Hainan Sanye Pharmaceutical Factory Co., Ltd. Business Overview Table 93. Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Product Portfolio Table 95. Hainan Sanye Pharmaceutical Factory Co., Ltd. Recent Development Table 96. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information Table 97. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview Table 98. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Product Portfolio Table 100. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Development Table 101. Southwest Pharmaceutical Co., Ltd. Company Information Table 102. Southwest Pharmaceutical Co., Ltd. Business Overview Table 103. Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio Table 105. Southwest Pharmaceutical Co., Ltd. Recent Development Table 106. North America Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 108. North America Rifaximin Capsules Sales Market Share by Country (2021-2026) Table 109. North America Rifaximin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Rifaximin Capsules Sales Market Share Forecast by Country (2027-2032) Table 111. North America Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Rifaximin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Rifaximin Capsules Market Share by Country (2021-2026) Table 114. North America Rifaximin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Rifaximin Capsules Market Share Forecast by Country (2027-2032) Table 116. Europe Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 118. Europe Rifaximin Capsules Sales Market Share by Country (2021-2026) Table 119. Europe Rifaximin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Rifaximin Capsules Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Rifaximin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Rifaximin Capsules Market Share by Country (2021-2026) Table 124. Europe Rifaximin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Rifaximin Capsules Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Rifaximin Capsules Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Rifaximin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Rifaximin Capsules Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Rifaximin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Rifaximin Capsules Market Share by Country (2021-2026) Table 134. Asia-Pacific Rifaximin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Rifaximin Capsules Market Share Forecast by Country (2027-2032) Table 136. Latin America Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 138. Latin America Rifaximin Capsules Sales Market Share by Country (2021-2026) Table 139. Latin America Rifaximin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Rifaximin Capsules Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Rifaximin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Rifaximin Capsules Market Share by Country (2021-2026) Table 144. Latin America Rifaximin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Rifaximin Capsules Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Rifaximin Capsules Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Rifaximin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Rifaximin Capsules Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Rifaximin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Rifaximin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Rifaximin Capsules Market Share by Country (2021-2026) Table 154. Middle East and Africa Rifaximin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Rifaximin Capsules Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Rifaximin Capsules Distributors List Table 159. Rifaximin Capsules Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Rifaximin Capsules Image Figure 2. Global Rifaximin Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifaximin Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Rifaximin Capsules Sales (2021-2032) & (K Units) Figure 5. 0.1g Image Figure 6. Global 0.1g Sales YoY Growth (2021-2032) & (K Units) Figure 7. 0.2g Image Figure 8. Global 0.2g Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Rifaximin Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rifaximin Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Rifaximin Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Rifaximin Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Rifaximin Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rifaximin Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rifaximin Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rifaximin Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rifaximin Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rifaximin Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rifaximin Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rifaximin Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rifaximin Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Rifaximin Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Rifaximin Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Rifaximin Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Rifaximin Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Rifaximin Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Rifaximin Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Rifaximin Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Rifaximin Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Rifaximin Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Rifaximin Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Rifaximin Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Rifaximin Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Rifaximin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Rifaximin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Rifaximin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Rifaximin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Rifaximin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Rifaximin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rifaximin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Rifaximin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Rifaximin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Rifaximin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rifaximin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Rifaximin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Rifaximin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Rifaximin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rifaximin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Rifaximin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Rifaximin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Rifaximin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rifaximin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Rifaximin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Rifaximin Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Rifaximin Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aden Healthcare
  • Alfasigma SpA
  • Estrellas Life Sciences Private Limited
  • Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  • Hainan Sanye Pharmaceutical Factory Co., Ltd.
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rifaximin Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rifaximin Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rifaximin Capsules Market by Type
  6. 1.3.1 0.1g
  7. 1.3.2 0.2g
  8. 1.4 Global Rifaximin Capsules Market Size by Type
  9. 1.4.1 Global Rifaximin Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rifaximin Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rifaximin Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rifaximin Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rifaximin Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rifaximin Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rifaximin Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rifaximin Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rifaximin Capsules Industry Trends
  2. 2.2 Rifaximin Capsules Industry Drivers
  3. 2.3 Rifaximin Capsules Industry Opportunities and Challenges
  4. 2.4 Rifaximin Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rifaximin Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Rifaximin Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Rifaximin Capsules Price (2021-2026)
  4. 3.4 Global Rifaximin Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rifaximin Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Rifaximin Capsules Company, Product Type & Application
  7. 3.7 Global Rifaximin Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rifaximin Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rifaximin Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rifaximin Capsules Tier 1, Tier 2, and Tier 3
4 Rifaximin Capsules Regional Status and Outlook
  1. 4.1 Global Rifaximin Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rifaximin Capsules Historic Market Size by Region
  3. 4.2.1 Global Rifaximin Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rifaximin Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rifaximin Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rifaximin Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Rifaximin Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rifaximin Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rifaximin Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rifaximin Capsules by Application
  1. 5.1 Rifaximin Capsules Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Rifaximin Capsules Market Size by Application
  6. 5.2.1 Global Rifaximin Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rifaximin Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rifaximin Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rifaximin Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rifaximin Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rifaximin Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rifaximin Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rifaximin Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aden Healthcare
  2. 6.1.1 Aden Healthcare Company Information
  3. 6.1.2 Aden Healthcare Business Overview
  4. 6.1.3 Aden Healthcare Rifaximin Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aden Healthcare Rifaximin Capsules Product Portfolio
  6. 6.1.5 Aden Healthcare Recent Developments
  7. 6.2 Alfasigma SpA
  8. 6.2.1 Alfasigma SpA Company Information
  9. 6.2.2 Alfasigma SpA Business Overview
  10. 6.2.3 Alfasigma SpA Rifaximin Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Alfasigma SpA Rifaximin Capsules Product Portfolio
  12. 6.2.5 Alfasigma SpA Recent Developments
  13. 6.3 Estrellas Life Sciences Private Limited
  14. 6.3.1 Estrellas Life Sciences Private Limited Company Information
  15. 6.3.2 Estrellas Life Sciences Private Limited Business Overview
  16. 6.3.3 Estrellas Life Sciences Private Limited Rifaximin Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Estrellas Life Sciences Private Limited Rifaximin Capsules Product Portfolio
  18. 6.3.5 Estrellas Life Sciences Private Limited Recent Developments
  19. 6.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  20. 6.4.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio
  24. 6.4.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Hainan Sanye Pharmaceutical Factory Co., Ltd.
  26. 6.5.1 Hainan Sanye Pharmaceutical Factory Co., Ltd. Company Information
  27. 6.5.2 Hainan Sanye Pharmaceutical Factory Co., Ltd. Business Overview
  28. 6.5.3 Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Product Portfolio
  30. 6.5.5 Hainan Sanye Pharmaceutical Factory Co., Ltd. Recent Developments
  31. 6.6 Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  32. 6.6.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information
  33. 6.6.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview
  34. 6.6.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Product Portfolio
  36. 6.6.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments
  37. 6.7 Southwest Pharmaceutical Co., Ltd.
  38. 6.7.1 Southwest Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio
  42. 6.7.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Rifaximin Capsules Sales by Country
  2. 7.1.1 North America Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rifaximin Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Rifaximin Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rifaximin Capsules Market Size by Country
  6. 7.2.1 North America Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rifaximin Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Rifaximin Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rifaximin Capsules Sales by Country
  2. 8.1.1 Europe Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rifaximin Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Rifaximin Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rifaximin Capsules Market Size by Country
  6. 8.2.1 Europe Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rifaximin Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rifaximin Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rifaximin Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rifaximin Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rifaximin Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rifaximin Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rifaximin Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rifaximin Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rifaximin Capsules Sales by Country
  2. 10.1.1 South America Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rifaximin Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Rifaximin Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rifaximin Capsules Market Size by Country
  6. 10.2.1 South America Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rifaximin Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Rifaximin Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rifaximin Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Rifaximin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rifaximin Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rifaximin Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rifaximin Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Rifaximin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rifaximin Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rifaximin Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rifaximin Capsules Value Chain Analysis
  2. 12.1.1 Rifaximin Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rifaximin Capsules Production Mode & Process
  7. 12.2 Rifaximin Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rifaximin Capsules Distributors
  10. 12.2.3 Rifaximin Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst